Search
Displaying results 591 to 600 of 673.
TWINCORE Symposium 2021 also digitally successful
At the opening of the event, TWINCORE Director Ulrich Kalinke looked back on last year's symposium and the course of the COVID19 pandemic. "At our last symposium, we looked at basic research on SARS-CoV-2," Kalinke said. "At that time, it was still unclear if and when…
Stronger together: EMBL and Helmholtz Health formalise their collaboration in research and development
Data science, microbiome research, environmental research, infection biology, and health and disease research with a special focus on cancer and antibiotics – these interdisciplinary topics are the focus of the memorandum of understanding (MoU) signed by EMBL and…
Want some more?
Your new paper is about the natural product darobactin. Where does this molecule come from and why is it so interesting for you? Darobactin is an antibiotic that was first described by Imai and colleagues in the journal Nature in 2019 and is naturally produced by the…
Helmholtz Data Science Career Day
At the Helmholtz Data Science Career Day on September 22, 2021, centers and partner institutions will now come together to present career opportunities from PhD to professorship in all research areas to international Data Science talents. The early afternoon conference…
Strengthening of Drug Bioinformatics at the Saarbrücken Site
With additional funding of €100,000, the Klaus Faber Foundation supports Kalinina's project "bioINFpro," which aims to expand drug research through AI-based methods and develop new antibiotics against antibiotic-resistant bacteria. In doing so, the foundation makes a…
Four new junior research groups at the Helmholtz Centre for Infection Research
The ability to react to changes, to survive in existing habitats and to colonize new ones is a prerequisite for prevailing in the course of evolution. These principles of resilience and adaptability, especially in microorganisms, are at the heart of the HZI project…
Jump start for young female scientists
What sparked your interest in pharmaceutical research and how did you come to HIPS in particular? I find pharmaceutical research so exciting because it is so interdisciplinary and translational. When I decided to study pharmacy, I deliberately didn't want to focus on…
On the effectiveness of non-pharmaceutical interventions to combat pathogens
The novel coronavirus known as SARS-CoV-2 first appeared in the Chinese city of Wuhan at the end of 2019 and spread rapidly around the world. The first case in Germany was confirmed in January 2020. In early 2020, SARS-CoV-2 was identified as the cause of the infectious…